Derivative Financial Instruments

3 Months Ended

Sep. 30, 2011

Derivative Financial Instruments

Derivative Financial Instruments

NOTE 12.    DERIVATIVE FINANCIAL INSTRUMENTS

The Company operates in several foreign countries, which exposes it to market risk associated with foreign currency exchange rate fluctuations. The Company's risk management policy is to enter into cash flow hedges to reduce a portion of the exposure of the Company's foreign subsidiaries' revenues to fluctuations in currency rates using foreign currency forward contracts. The Company also enters into cash flow hedges for a portion of its forecasted inventory purchases to reduce the exposure of its Canadian and Australian subsidiaries' cost of sales to such fluctuations. The principal currencies hedged are British pounds, Euros, Canadian dollars and Australian dollars. The Company does not enter into derivative financial contracts for speculative or trading purposes. The Company's derivative financial instruments are recorded in the consolidated balance sheets at fair value determined using pricing models based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions. Cash flows from derivative financial instruments are classified as cash flows from operating activities in the consolidated statements of cash flows.

          Foreign currency contracts used to hedge forecasted revenues are designated as cash flow hedges.  These contracts are used to hedge forecasted subsidiaries' revenues generally over approximately 12 to 24 months.  Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income (loss) within shareholders' equity to the extent such contracts are effective, and are recognized in net sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring.  Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three months ended September 30, 2011 or in fiscal 2011 relating to foreign currency contracts used to hedge forecasted revenues resulting from hedge ineffectiveness.  As of September 30, 2011, the Company had notional amounts of 9.0 million British pounds and 3.2 million Euros under foreign currency contracts used to hedge forecasted revenues that expire between October 31, 2011 and May 31, 2012.

Foreign currency contracts used to hedge forecasted cost of sales are designated as cash flow hedges. These contracts are used to hedge forecasted Canadian and Australian subsidiaries' cost of sales generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income (loss) within shareholders'

equity, to the extent such contracts are effective, and are recognized in cost of sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring.  Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately.   There were no amounts recorded in the three months ended September 30, 2011 or in fiscal 2011 relating to foreign currency contracts used to hedge forecasted cost of sales resulting from hedge ineffectiveness.  As of September 30, 2011, the Company had notional amounts of 20.8 million Canadian dollars and 8.5 million Australian dollars under foreign currency contracts used to hedge forecasted cost of sales that expire between September 30, 2011 and May 31, 2013.

When appropriate, the Company also enters into and settles foreign currency contracts for Euros, British pounds and Canadian dollars to reduce exposure of the Company's foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. These contracts are used to hedge balance sheet exposure generally over one month and are settled before the end of the month in which they are entered into. Changes to fair value of the forward contracts are recognized in selling, general and administrative expense in the period in which the contracts expire. For the three months ended September 30, 2011 and 2010, the Company recorded a gain of $1.1 million and a loss of $1.9 million, respectively in selling, general and administrative expenses related to these contracts. As of September 30, 2011, there were no such foreign currency contracts outstanding. There were no amounts recorded in the three months ended September 30, 2011 or in fiscal 2011 relating to foreign currency contracts to hedge subsidiary balance sheets resulting from hedge ineffectiveness.

The following tables illustrate the fair value of outstanding foreign currency contracts and the gains (losses) associated with the settlement of these contracts:

	Fair Value of Derivative Instruments
(Amounts in thousands)	Asset Derivatives
	As of  September 30, 2011
	Balance Sheet Location	Fair
		Value
Derivatives designated as effective hedges
Foreign Currency Contracts	Other assets	$	1,608
Total		$	1,608

As of June 30, 2011, the Company's foreign currency contracts were measured at fair value as a liability of $2.0 million.

Gain (Loss) Recognized in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)

(Amounts in thousands)	Three Months Ended
	September 30,		September 30,
	2011		2010
Currency Contracts- Sales	$	652	$	(1,020)
Currency Contracts - Cost of Sales		2,036		(792)
Total	$	2,688	$	(1,812

Loss Reclassified from Accumulated Other Comprehensive Income into Income (Effective Portion)

(Amounts in thousands)	Three Months Ended
	September 30,			September 30,
	2011			2010
Currency Contracts - Sales (1)	$	(56	)	$	(35)
Currency Contracts - Cost of Sales (2)		(619	)		(120)
Total	$	(675	)	$	(155)
(1)   Recorded in net sales on the consolidated statements of operations.
(2)   Recorded in cost of sales on the consolidated statements of operations.